eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2019
vol. 70
 
Share:
Send email
Share:
abstract:
Original paper

Association of breast cancer grade with response to neoadjuvant chemotherapy assessed postoperatively

Michał Jarząb
1
,
Ewa Stobiecka
1
,
Agnieszka Badora-Rybicka
1
,
Ewa Chmielik
1
,
Małgorzata Kowalska
1
,
Wiesław Bal
1
,
Anna Polakiewicz-Gilowska
1
,
Barbara Bobek-Billewicz
1
,
Dariusz Lange
1
,
Rafał Tarnawski
1

  1. Department of Thoracic Surgery, Jinan Central Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong Province, People’s Republic of China
Pol J Pathol 2019; 70 (2): 91-99
DOI: https://doi.org/10.5114/pjp.2019.87101
Online publish date: 2019/08/29
View full text Get citation
 
PlumX metrics:
Currently, breast cancer chemotherapy response can be predicted based on various parameters, with common reporting of tumour grade and Ki67 proliferation index. We analysed their association with pathological complete response (pCR) in a multivariate approach.

The study was carried out in a group of 353 patients, treated by preoperative chemotherapy and prospectively observed. In selected patients, parallel to routing core needle biopsy assessment, gene expression profile of tumour was analysed by oligonucleotide microarrays.

Tumour parameters associated with pCR in univariate analysis were: tumour grade, nuclear grade, mitotic index, Ki67, oestrogen and progesterone receptor (all p < 0.0001), and triple-negative status (p = 0.0032). The highest increase of pCR chance was observed in patients with high-grade tumours and with Ki67 ≥ 20%. In multivariate analysis, only tumour grade and oestrogen receptor status were predictive for pCR independently of other variables, with high grade increasing the odds of pCR 2.42 fold, and high ER decreasing the chance of pCR 0.41 fold. Tumour grading reflects important biological features of breast cancer and is not inferior to proliferation markers, including Ki67. It should be taken into account in decision-making for preoperative chemotherapy in parallel to breast cancer biologic subtypes, because grade 3 tumours exhibit a higher proportion of pCR.
keywords:

breast cancer, preoperative chemotherapy, grading
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.